TIM
GILD icon

Tortoise Investment Management’s Gilead Sciences GILD Stock Holding History

Tortoise Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,000
Closed -$9K – 364
2013
Q4 		$9K Hold
1,000
– – ﹤0.01% 251
2013
Q3 		$4K Sell
1,000
-1,400
-58% -$83.7K ﹤0.01% 280
2013
Q2 		$25K Buy
+2,400
New +$125K 0.02% 184

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Tortoise Investment Management's GILD Position: Q4 2025 in Review

Tortoise Investment Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 78 shares — an estimated $8.66K sold.

Tortoise Investment Management first reported a position in GILD in Q2 2013 and held it in 45 quarters. The position peaked at $310K in Q2 2015. 2,217 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Tortoise Investment Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Tortoise Investment Management sold 78 Gilead Sciences shares in Q4 2025, an estimated $8.66K.
  • Tortoise Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 45 quarters.
  • Tortoise Investment Management's Gilead Sciences position peaked at $310K in Q2 2015.
  • 2,217 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.